909 |
Scientific Interpretation of ACCORD- LIPID |
Ki Hoon Han |
May. 03. 10 |
908 |
Why CAS? |
William A. Gray |
May. 03. 10 |
907 |
New Devices in CTO treatment - Clinical Outcome Comparison |
Dierk Scheinert |
May. 03. 10 |
906 |
Future of BTK/CLI treatment |
Dierk Scheinert |
May. 03. 10 |
905 |
LEADERS Clinical Results, Insights into Complex Patient Population and OCT Findings |
Antonio Colombo |
May. 03. 10 |
904 |
NOBORI Japan Trial Up-Date |
Yuji Ikari |
May. 03. 10 |
903 |
NOBORI 2 Latest Findings |
Gian Battista Danzi |
May. 03. 10 |
902 |
NOBORI 1 Data Up-Date |
Bernard R. Chevalier |
May. 03. 10 |
901 |
Cost-Effectiveness of Prasugrel vs. Clopidogrel in ACS |
David Joel Cohen |
May. 03. 10 |
900 |
A High Risk Patients\' Cohort, Age over 70 and 80 Years in the Worldwide eHEALING Registry |
Andres Iniguez |
May. 03. 10 |